Mackay Shields LLC Vir Biotechnology, Inc. Transaction History

Mackay Shields LLC

  • $581 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$38.75 - $51.0 $964,875 - $1.27 Million
-24,900 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$26.34 - $83.07 $474,120 - $1.5 Million
-18,000 Reduced 41.96%
24,900 $1.28 Million
Q4 2020

Feb 16, 2021
BUY
$25.51 - $43.38 $209,182 - $355,716
8,200 Added 23.63%
42,900 $1.15 Million
Q3 2020

Nov 04, 2020
BUY
$28.28 - $53.6 $981,316 - $1.86 Million
34,700 New
34,700 $1.19 Million

Others Institutions Holding VIR

# of Institutions
219
Shares Held
87.4M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $1.04B
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Mackay Shields LLC Portfolio

Follow Mackay Shields LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email